Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 167114
                    [Title] => BP drug launched
                    [Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.


A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.


The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease. 


                    [DatePublished] => 2002-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 167165
                    [Title] => BP drug launched
                    [Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.


A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.


The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease. 


                    [DatePublished] => 2002-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

PERINDOPRIL AND INDAPAMIDE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 167114
                    [Title] => BP drug launched
                    [Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.


A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.


The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease. 


                    [DatePublished] => 2002-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 167165
                    [Title] => BP drug launched
                    [Summary] => The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on.


A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept, was formally launched at the recent annual convention of the Philippine Heart Association (PHA) at the EDSA Shangri-La Hotel.


The symposium, organized in cooperation with leading pharmaceutical company Servier Phils., featured two internationally renowned speakers, both experts in the fields of high blood pressure and heart disease. 


                    [DatePublished] => 2002-07-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

BP drug launched

July 4, 2002 - 12:00am

The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on. A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept,...

Science and Environment

BP drug launched

July 4, 2002 - 12:00am

The research for an ideal blood-pressure (BP) lowering drug which is effective but with minimal side-effects is still on. A unique drug called Preterax, based on the novel very-low-dose combination (VLCD) concept,...

Science and Environment